Biotech Stocks: Drug stocks mixed; Pfizer climbs on Lipitor deal
BOSTON (MarketWatch) -- Drug stocks were mixed in early action Wednesday as shares of Pfizer Inc. climbed on news that it has agreed to have Indian group Ranbaxy Laboratories Ltd. sell a generic version of Pfizer's blockbuster cholesterol-controlling... 2 months ago
MarketWatch Click here to Read the Full Story